A Breakthrough Treatment for Treatment-Resistant Depression
At Illumma, we are dedicated to providing innovative and science-backed treatments to help individuals struggling with mental health challenges. We are proud to offer Spravato (esketamine) therapy, an FDA-approved nasal spray treatment for adults with treatment-resistant depression (TRD) and major depressive disorder with suicidal ideation (MDSI).
Unlike traditional antidepressants that can take weeks or months to take effect, Spravato works rapidly, offering relief within hours or days. If you have tried at least two antidepressant medications without success, Spravato may be the breakthrough treatment you’ve been searching for.

